Continuation of fluoropyrimidine treatment with s-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study☆

HIGHLIGHTS

• who: P. Osterlund from the Department of, Tampere University and University of Tampere, Tampere, Finland have published the paper: Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort studyu2606, in the Journal: (JOURNAL) of 10/05/2021
• what: The study was, therefore, expanded to other centers to include 200 patients, which provided an estimated 95% CI of 12.5% to 17.5%. Patients in this study had 5-FU and capecitabine administered with different techniques and with various . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.